235 related articles for article (PubMed ID: 1588147)
1. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b.
Glezen WP; Englund JA; Siber GR; Six HR; Turner C; Shriver D; Hinkley CM; Falcao O
J Infect Dis; 1992 Jun; 165 Suppl 1():S134-6. PubMed ID: 1588147
[TBL] [Abstract][Full Text] [Related]
2. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
Mulholland K; Suara RO; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen WP; Francis N; Fritzell B; Greenwood BM
JAMA; 1996 Apr; 275(15):1182-8. PubMed ID: 8609686
[TBL] [Abstract][Full Text] [Related]
3. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.
Englund JA; Glezen WP; Turner C; Harvey J; Thompson C; Siber GR
J Infect Dis; 1995 Jan; 171(1):99-105. PubMed ID: 7798688
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae type b-specific antibody in infants after maternal immunization.
Englund JA; Glezen WP; Thompson C; Anwaruddin R; Turner CS; Siber GR
Pediatr Infect Dis J; 1997 Dec; 16(12):1122-30. PubMed ID: 9427456
[TBL] [Abstract][Full Text] [Related]
5. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
[TBL] [Abstract][Full Text] [Related]
6. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
8. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.
Ward J; Brenneman G; Letson GW; Heyward WL
N Engl J Med; 1990 Nov; 323(20):1393-401. PubMed ID: 2233906
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
10. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
12. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
Lepow ML; Samuelson JS; Gordon LK
J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections.
Trollfors B; Lagergård T; Claesson BA; Thornberg E; Martinell J; Schneerson R
J Infect Dis; 1992 Dec; 166(6):1335-9. PubMed ID: 1431250
[TBL] [Abstract][Full Text] [Related]
15. Relation between enzyme-linked immunosorbent assay and radioimmunoassay for detection of antibodies to the capsular polysaccharide of Haemophilus influenzae type b.
Kristensen K; Bentzon MW
APMIS; 1992 Feb; 100(2):142-6. PubMed ID: 1554488
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Haemophilus influenzae type B vaccines in children with hepatoportoenterostomies.
Rosenthal P; Wong V; Ross LA; Kim KS
J Pediatr Gastroenterol Nutr; 1990 Aug; 11(2):201-4. PubMed ID: 2395059
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
18. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b.
Anderson P; Pichichero ME; Insel RA
J Pediatr; 1985 Sep; 107(3):346-51. PubMed ID: 3875705
[TBL] [Abstract][Full Text] [Related]
19. Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b.
Hetherington SV; Rutkowski AF
J Infect Dis; 1990 Nov; 162(5):1185-8. PubMed ID: 2230242
[TBL] [Abstract][Full Text] [Related]
20. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
